These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15974948)

  • 21. Structure-function study and anti-HIV activity of synthetic peptide analogues derived from viral chemokine vMIP-II.
    Luo Z; Fan X; Zhou N; Hiraoka M; Luo J; Kaji H; Huang Z
    Biochemistry; 2000 Nov; 39(44):13545-50. PubMed ID: 11063591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Designing decoys for chemokine-chemokine receptor interaction.
    Rajarathnam K
    Curr Pharm Des; 2002; 8(24):2159-69. PubMed ID: 12369860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokines as natural HIV antagonists.
    Verani A; Lusso P
    Curr Mol Med; 2002 Dec; 2(8):691-702. PubMed ID: 12462390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural studies of chemokines that inhibit HIV-1 entry.
    Fernandez EJ; Lolis E
    Antivir Chem Chemother; 2001; 12 Suppl 1():43-9. PubMed ID: 11594687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
    Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-specific polymer attachment to a CCL-5 (RANTES) analogue by oxime exchange.
    Shao H; Crnogorac MM; Kong T; Chen SY; Williams JM; Tack JM; Gueriguian V; Cagle EN; Carnevali M; Tumelty D; Paliard X; Miranda LP; Bradburne JA; Kochendoerfer GG
    J Am Chem Soc; 2005 Feb; 127(5):1350-1. PubMed ID: 15686348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides.
    Secchi M; Longhi R; Vassena L; Sironi F; Grzesiek S; Lusso P; Vangelista L
    Chem Biol; 2012 Dec; 19(12):1579-88. PubMed ID: 23261601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-HIV-1 peptides derived from partial amino acid sequences of CC-chemokine RANTES. Regulated upon activation, normal T-cell expressed and secreted.
    Nishiyama Y; Murakami T; Shikama S; Kurita K; Yamamoto N
    Bioorg Med Chem; 2002 Dec; 10(12):4113-7. PubMed ID: 12413865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokine: receptor structure, interactions, and antagonism.
    Allen SJ; Crown SE; Handel TM
    Annu Rev Immunol; 2007; 25():787-820. PubMed ID: 17291188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation.
    Polo S; Nardese V; De Santis C; Arcelloni C; Paroni R; Sironi F; Verani A; Rizzi M; Bolognesi M; Lusso P
    Eur J Immunol; 2000 Nov; 30(11):3190-8. PubMed ID: 11093134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemokine analogues show suitable stability for development as microbicides.
    Cerini F; Landay A; Gichinga C; Lederman MM; Flyckt R; Starks D; Offord RE; Le Gal F; Hartley O
    J Acquir Immune Defic Syndr; 2008 Dec; 49(5):472-6. PubMed ID: 18989226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation.
    Fernandez EJ; Wilken J; Thompson DA; Peiper SC; Lolis E
    Biochemistry; 2000 Oct; 39(42):12837-44. PubMed ID: 11041848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II.
    Zhou N; Luo Z; Luo J; Hall JW; Huang Z
    Biochemistry; 2000 Apr; 39(13):3782-7. PubMed ID: 10736178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
    Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
    J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure, function and modulation of chemokine receptors: members of the g-protein-coupled receptor superfamily.
    Huang Z
    Mini Rev Med Chem; 2002 Aug; 2(4):373-83. PubMed ID: 12370058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
    Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
    Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemokines and chemokine receptors. Review article].
    Niederlová J; Koubek K
    Sb Lek; 1999; 100(3):169-89. PubMed ID: 11221465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analogues of N-terminal truncated synthetic peptide fragments derived from RANTES inhibit HIV-1 infectivity.
    Ramnarine EJ; Devico AL; Vigil-Cruz SC
    Bioorg Med Chem Lett; 2006 Jan; 16(1):93-5. PubMed ID: 16236501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemokines and defense-system cell homing].
    Galanaud P; Richard Y; Emilie D
    J Soc Biol; 2001; 195(1):9-12. PubMed ID: 11530508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.